Fondaparinux vs warfarin for the treatment of unsuspected pulmonary embolism in cancer patients

Fondaparinux vs warfarin for the treatment of unsuspected pulmonary embolism in cancer patients

Bruno Amato,1,2,* Rita Compagna,1,2,* Aldo Rocca,2 Tommaso Bianco,2 Marco Milone,2 Luigi Sivero,2 Gabriele Vigliotti,2 Maurizio Amato,2 Michele Danzi,2 Giovanni Aprea,2 Luca Gallelli,3,* Stefano de Franciscis,1,4,* Raffaele Serra1,4,* 1Interuniversity Center of Phlebolymphology, International Resea...

Szczegółowa specyfikacja

Opis bibliograficzny
Główni autorzy: Amato B, Compagna R, Rocca A, Bianco T, Milone M, Sivero L, Vigliotti G, Amato M, Danzi M, Aprea G, Gallelli L, de Franciscis S, Serra R
Format: Artykuł
Język:English
Wydane: Dove Medical Press 2016-06-01
Seria:Drug Design, Development and Therapy
Hasła przedmiotowe:
cancer patients
asymptomatic pulmonary embolism
fondaparinux
warfarin
Dostęp online:https://www.dovepress.com/fondaparinux-vs-warfarin-for-the-treatment-of-unsuspected-pulmonary-em-peer-reviewed-article-DDDT

Internet

https://www.dovepress.com/fondaparinux-vs-warfarin-for-the-treatment-of-unsuspected-pulmonary-em-peer-reviewed-article-DDDT

Podobne zapisy